These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 15313517

  • 1. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J, Al-Semaan Y, Drost DJ, Malla AK, Neufeld RW, Bartha R, Manchanda R, Menon R, Densmore M, Schaefer B, Williamson PC.
    Psychiatry Res; 2004 Jul 30; 131(2):107-14. PubMed ID: 15313517
    [Abstract] [Full Text] [Related]

  • 2. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.
    Psychiatry Res; 2004 Jul 30; 131(2):95-105. PubMed ID: 15313516
    [Abstract] [Full Text] [Related]

  • 3. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct 30; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
    Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C.
    Arch Gen Psychiatry; 2006 Sep 30; 63(9):969-76. PubMed ID: 16952999
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.
    Fujimoto T, Nakano T, Takano T, Takeuchi K, Yamada K, Fukuzako T, Akimoto H.
    Biol Psychiatry; 1996 Jul 01; 40(1):14-8. PubMed ID: 8780850
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. White-matter markers for psychosis in a prospective ultra-high-risk cohort.
    Bloemen OJ, de Koning MB, Schmitz N, Nieman DH, Becker HE, de Haan L, Dingemans P, Linszen DH, van Amelsvoort TA.
    Psychol Med; 2010 Aug 01; 40(8):1297-304. PubMed ID: 19895720
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients].
    Başoğlu C, Cetin M, Oner O, Ebrinç S, Semiz UB, Kandilcioğlu H, Silit E, Kizilkaya E.
    Turk Psikiyatri Derg; 2006 Aug 01; 17(2):85-91. PubMed ID: 16755408
    [Abstract] [Full Text] [Related]

  • 12. Regional gray matter volume abnormalities in the at risk mental state.
    Borgwardt SJ, Riecher-Rössler A, Dazzan P, Chitnis X, Aston J, Drewe M, Gschwandtner U, Haller S, Pflüger M, Rechsteiner E, D'Souza M, Stieglitz RD, Radü EW, McGuire PK.
    Biol Psychiatry; 2007 May 15; 61(10):1148-56. PubMed ID: 17098213
    [Abstract] [Full Text] [Related]

  • 13. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
    Sigmundsson T, Maier M, Toone BK, Williams SC, Simmons A, Greenwood K, Ron MA.
    Schizophr Res; 2003 Nov 01; 64(1):63-71. PubMed ID: 14511802
    [Abstract] [Full Text] [Related]

  • 14. Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia.
    Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2009 Feb 01; 15(2):CR82-88. PubMed ID: 19179972
    [Abstract] [Full Text] [Related]

  • 15. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.
    Auer DP, Wilke M, Grabner A, Heidenreich JO, Bronisch T, Wetter TC.
    Schizophr Res; 2001 Oct 01; 52(1-2):87-99. PubMed ID: 11595395
    [Abstract] [Full Text] [Related]

  • 16. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A, Galińska B, Tarasów E, Kubas B, Dzienis W, Konarzewska B, Poplawska R, Tomczak AA, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2007 May 01; 13 Suppl 1():17-22. PubMed ID: 17507880
    [Abstract] [Full Text] [Related]

  • 17. Hippocampal 1H MRS in first-episode bipolar I patients.
    Atmaca M, Yildirim H, Ozdemir H, Poyraz AK, Tezcan E, Ogur E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1235-9. PubMed ID: 16725248
    [Abstract] [Full Text] [Related]

  • 18. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C.
    Arch Gen Psychiatry; 2006 Feb 30; 63(2):139-49. PubMed ID: 16461856
    [Abstract] [Full Text] [Related]

  • 19. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals.
    Wood SJ, Berger G, Velakoulis D, Phillips LJ, McGorry PD, Yung AR, Desmond P, Pantelis C.
    Schizophr Bull; 2003 Feb 30; 29(4):831-43. PubMed ID: 14989417
    [Abstract] [Full Text] [Related]

  • 20. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS, Chiang IC, Li CW, Lin WC, Lu CY, Hsieh TJ, Liu GC, Lin HF, Kuo YT.
    Psychiatry Res; 2009 Jun 30; 172(3):210-4. PubMed ID: 19303260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.